FutureChem Co.,Ltd (KOSDAQ:220100)
South Korea · Delayed Price · Currency is KRW 18,130
-10 (-0.06%)
Aug 8, 2025, 3:30 PM KST
Verve Therapeutics Market Cap
FutureChem Co.,Ltd has a market cap or net worth of 400.84 billion as of August 8, 2025. Its market cap has decreased by -7.54% in one year.
Market Cap
400.84B
Enterprise Value
379.41B
Revenue
18.93B
Ranking
n/a
PE Ratio
n/a
Stock Price
$18,130.00
Market Cap Chart
Since December 1, 2016, FutureChem Co.,Ltd's market cap has increased from 62.12B to 400.84B, an increase of 545.22%. That is a compound annual growth rate of 23.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 400.84B | 4.79% |
| Dec 30, 2024 | 382.50B | 64.08% |
| Dec 28, 2023 | 233.12B | 9.76% |
| Dec 29, 2022 | 212.38B | -14.94% |
| Dec 30, 2021 | 249.70B | -19.28% |
| Dec 30, 2020 | 309.32B | 288.47% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.38T |
| Celltrion | 39.35T |
| ALTEOGEN | 23.49T |
| Yuhan | 8,568.09B |
| SK Biopharmaceuticals | 7,948.79B |
| Peptron | 7,292.07B |
| PharmaResearch | 6,213.01B |
| HLB Co., Ltd. | 6,099.84B |